EPO and diabetes mellitus: Sex, level of education, relationship status, prevalence of HIV infection and cardiovascular disease, recombinant erythropoietin (rEPO) dose, and serum urea and calcium showed no significant difference between groups; prevalence of diabetes was similar between patients prescribed PD and those prescribed HD (p = 0.611).